Innovus Pharmaceuticals Inc
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Innovus Pharmaceuticals Inc COMMON, CUSIP 45778V106.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Innovus Pharmaceuticals Inc COMMON, CUSIP 45778V106.